Milestone Medical, Inc. reported unaudited consolidated financial results for the third quarter and nine months ended September 30, 2016. For the quarter, the company reported product sales, net of $3,186,596 against $2,459,958 for the same period of last year. Loss from operations was $1,568,183 against $835,357 for the same period of last year. Loss before provision for income taxes was $1,569,029 against $836,400 for the same period of last year. Net loss attributable to company was $1,701,250 or $0.05 per basic and diluted share against $1,569,202 or $0.07 per basic and diluted share for the same period of last year. For the nine months, the company reported product sales, net of $8,973,726 against $6,996,921 for the same period of last year. Loss from operations was $4,683,933 against $2,320,189 for the same period of last year. Loss before provision for income taxes was $4,686,715 against $2,321,150 for the same period of last year. Net loss attributable to company was $4,207,670 or $0.16 per basic and diluted share against $4,061,525 or $0.19 per basic and diluted share for the same period of last year.